Low-dose apixaban in extended treatment of cancer-associated thrombosis: Less is more?

J Thromb Haemost. 2022 May;20(5):1070-1072. doi: 10.1111/jth.15685.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants / therapeutic use
  • Factor Xa Inhibitors / adverse effects
  • Humans
  • Neoplasms* / complications
  • Neoplasms* / drug therapy
  • Pyrazoles / adverse effects
  • Pyridones / adverse effects
  • Thrombosis* / drug therapy
  • Thrombosis* / etiology
  • Thrombosis* / prevention & control

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • Pyrazoles
  • Pyridones
  • apixaban